Literature DB >> 32541961

Biobanks could identify medically actionable findings relevant for COVID-19 clinical care.

Andrew B Stergachis1,2,3, Scott T Weiss4,5, Robert C Green6,4,7.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32541961     DOI: 10.1038/s41591-020-0953-x

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.

Authors:  Stephanie M LaVergne; Sophia Stromberg; Bridget A Baxter; Tracy L Webb; Taru S Dutt; Kailey Berry; Madison Tipton; Jared Haberman; Benjamin R Massey; Kim McFann; Omar Alnachoukati; Linda Zier; Thomas Heacock; Gregory D Ebel; Marcela Henao-Tamayo; Julie Dunn; Elizabeth P Ryan
Journal:  BMC Infect Dis       Date:  2021-07-13       Impact factor: 3.090

2.  Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United States.

Authors:  James M Stevenson; G Caleb Alexander; Natasha Palamuttam; Hemalkumar B Mehta
Journal:  Clin Transl Sci       Date:  2020-11-22       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.